Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2013-003938-32-AT
EUCTR2013-003938-32-AT
Active, not recruiting
Phase 1

Genetic alterations in genes coding for transporters and metformin resistance

Medizinische Universität Graz0 sites300 target enrollmentJanuary 13, 2014
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsWe want to investigate the pharmacokintetics of metformin in patients with type 2 diabetes or polycystic ovary syndrome in association with the patients genotypeTherapeutic area: Diseases [C] - Hormonal diseases [C19]

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
We want to investigate the pharmacokintetics of metformin in patients with type 2 diabetes or polycystic ovary syndrome in association with the patients genotype
Sponsor
Medizinische Universität Graz
Enrollment
300
Status
Active, not recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 13, 2014
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •adults (older than 18 years)
  • •type 2 diabetics and/or diagnosed PCOS
  • •at least 1 month on metformin therapy
  • •type 2 diabetics with change of therapy from metformin to another antidiabetic medication due to inefectiveness of metformin
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 270
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range 30

Exclusion Criteria

  • •Cushing's syndrome
  • •androgen\-secreting tumours

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Identification of the genetic pathways involved in patients overreacting to radiotherapy
NL-OMON35606MAASTRO clinic6
Completed
Not Applicable
The role of genetic polymorphisms in the CNS transport of endogenous metabolites and drugs in intensive care medicine.
DRKS00034342niversitätsmedizin Göttingen, Institut für klinische Pharmakologie100
Not yet recruiting
Not Applicable
Pathogenetic relevance of mutations in the Transthyretin gene in patients with polyneuropathyIdiopathic polyneuropathy
DRKS00018881niklinik Köln300
Recruiting
Not Applicable
Elucidation of genes involved in individual differences in ondansetron sensitivityPatients undergoing orthognathic surgery
JPRN-UMIN000051727Tokyo Dental College100
Recruiting
Not Applicable
Elucidating the genetic pathomechanism underlying rare and hereditary kidney diseases
DRKS00008910Institut für HumangenetikUniklinik Köln3,000